Copertina

Synergistic‐like decreases in alcohol intake following combined pharmacotherapy with GLP‐1 and amylin in male rats

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Cajsa Aranäs, Antonia Caffrey, Christian E. Edvardsson, Jesper Vestlund, Heath D. Schmidt, Elisabet Jerlhag
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Contribution of peripheral and central delta opioid receptors in the relief of migraine‐like headache in female and male rats
di: Manon Dussol, et al.
Pubblicazione: (2025)

Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
di: Feng Zhang, et al.
Pubblicazione: (2024)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients
di: Dávid Nagy, et al.
Pubblicazione: (2025)

Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models
di: Geoffrey Canet, et al.
Pubblicazione: (2025)

Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir
di: Mohamed Zamzamy, et al.
Pubblicazione: (2025)

The opioid partial agonist PPL‐138 reduces alcohol self‐administration in rats susceptible to post‐traumatic stress disorder
di: Andrea Cippitelli, et al.
Pubblicazione: (2025)

Feedback control of excitability and high K + induced epileptiform bursts in male rat hippocampal slices with a photocaged adenosine A 1 receptor agonist
di: Erine Craey, et al.
Pubblicazione: (2026)

Human vs . artificial intelligence: Physicians outperform ChatGPT in real‐world pharmacotherapy counselling
di: Benjamin Krichevsky, et al.
Pubblicazione: (2025)

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy
di: Tjitske M. van der Zanden, et al.
Pubblicazione: (2026)

Targeting acetylated high mobility group box 1 protein (HMGB1) and toll‐like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose‐fed rats
di: Yu‐Te Lin, et al.
Pubblicazione: (2024)

Exposure‐adjusted safety and efficacy of GLP‐I and GLP‐1/GIP receptor agonists compared with non‐GLP‐I for weight management and type 2 diabetes: Based on FDA medical and statistical reports of 34 280 safety and 36 312 efficacy subjects
di: Aishwarya Prasad, et al.
Pubblicazione: (2026)

RETRACTION: L6H21 protects against cognitive impairment and brain pathologies via toll‐like receptor 4–myeloid differentiation factor 2 Signalling in Prediabetic rats
Pubblicazione: (2025)

Pharmacokinetics and pharmacodynamics of intranasal insulin in a rat brain
di: Jelena Osmanovic Barilar, et al.
Pubblicazione: (2025)

Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum
di: Jieling Cai, et al.
Pubblicazione: (2024)

Biphasic effect of nicotine on glutamatergic activity in male mouse brain
di: Prajakta Pramod Biyani, et al.
Pubblicazione: (2025)

GLP‐1 agonist‐associated presentations to unscheduled care: An opportunistic pilot study
di: Oliver Thomas, et al.
Pubblicazione: (2025)

Sex influence on serotonergic modulation of the vascular noradrenergic drive in rats
di: Anaïs Clara Terol‐Úbeda, et al.
Pubblicazione: (2024)

Sevoflurane protects against testicular ischaemia–reperfusion injury in rats
di: Jiaxue Li, et al.
Pubblicazione: (2026)

Inhibition of peripheral CB 1 receptors modulates food intake and metabolic efficiency in obesity independently of the gut–brain vagal axis
di: Oriane Onimus, et al.
Pubblicazione: (2026)

Antibiotic‐induced decrease of bacterial load in guinea pig intestine reduces α2‐adrenoceptor expression and activity in peristaltic motor inhibition
di: Aitak Farzi, et al.
Pubblicazione: (2025)

Opportunities of patient‐derived organoids in drug development
di: Antonia Büning, et al.
Pubblicazione: (2025)

Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model
di: Rolien Bosch, et al.
Pubblicazione: (2024)

GLP‐1 receptor agonists and reduced dementia risk: Real‐world evidence stacks up
di: Yun Wah Lam, et al.
Pubblicazione: (2026)

The pancreatic signal of GLP‐1 receptor agonists: A biliary phenomenon rather than direct toxicity
di: Andro Koren, et al.
Pubblicazione: (2026)

The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats
di: Srinivas Kamath, et al.
Pubblicazione: (2024)

β 3 ‐adrenoceptor agonism exerts lung protection in a rat model of bronchopulmonary dysplasia
di: Alessandro Pini, et al.
Pubblicazione: (2026)

Time‐varying compartmental models capture hours‐scale variation in the elimination kinetics of vancomycin in rats
di: Matthew H. McDonough, et al.
Pubblicazione: (2025)

Ventral pallidum GABAergic and glutamatergic neurons modulate arousal during sevoflurane general anaesthesia in male mice
di: Bing‐Qian Fan, et al.
Pubblicazione: (2025)

The use of different types of networks, alone and in combination, for drug target identification
di: Paolo Parini
Pubblicazione: (2025)

AMG487 alleviates influenza A (H1N1) virus‐induced pulmonary inflammation through decreasing IFN‐γ‐producing lymphocytes and IFN‐γ concentrations
di: Wenbin Ding, et al.
Pubblicazione: (2024)

Myo‐inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline‐induced pulmonary hypertension in the rat
di: Marta Oknińska, et al.
Pubblicazione: (2024)

Schedule‐dependent neuroprotection by pioglitazone in a novel model of α‐synucleinopathy in rats: Integrated behavioural and histological outcomes
di: Alberto Santiago‐Balmaseda, et al.
Pubblicazione: (2026)

Correction to “Contribution of intercellular adhesion molecule 1 (ICAM‐1) to the pathogenesis of splanchnic artery occlusion shock in the rat”
Pubblicazione: (2024)

In vitro and in vivo study of butyrylfentanyl and 4‐fluorobutyrylfentanyl in female and male mice: Role of the CRF1 receptor in cardiorespiratory impairment
di: Sabrine Bilel, et al.
Pubblicazione: (2024)

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis
di: Andrej Belančić, et al.
Pubblicazione: (2026)

Paraoxonase‐2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non‐alcoholic steatohepatitis
di: Gu‐Choul Shin, et al.
Pubblicazione: (2024)

Methanobactin rapidly facilitates biliary copper excretion in a Wilson disease rat model visualised by 64 Cu PET/MRI
di: Emilie Munk Lynderup, et al.
Pubblicazione: (2025)

Correction to Improved survival and reversal of endothelial dysfunction by the 21‐aminosteroid, U‐74389G in splanchnic ischaemia‐reperfusion injury in the rat
Pubblicazione: (2024)

PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells
di: Dennis Reininger, et al.
Pubblicazione: (2024)

Toll‐like receptor 4 mediates lipopolysaccharide‐induced emesis
di: Luping Liu, et al.
Pubblicazione: (2026)